The genetic testing services for individualized tumor medications cover commom tumor-targeted drugs, 13 chemotherapy drugs, and PD-1/PD-L1 immunosuppressant drugs. 

By detecting the gene mutations of patients, to predict the efficacy of drugs, and provide professional clinical medication guidance, so as to achieve individualized tumor diagnosis and treatment.